The Targeted Translation Research Accelerator (TTRA) for Diabetes and Cardiovascular Disease is a nationally funded program that supports the development and commercialization of innovative solutions addressing unmet needs in diabetes and cardiovascular health. Through strategic funding, industry engagement, and translational research support, TTRA helps accelerate promising discoveries from research into clinical practice and patient impact across Australia. Learn more here.